RU2014115999A - Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии - Google Patents

Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии Download PDF

Info

Publication number
RU2014115999A
RU2014115999A RU2014115999/15A RU2014115999A RU2014115999A RU 2014115999 A RU2014115999 A RU 2014115999A RU 2014115999/15 A RU2014115999/15 A RU 2014115999/15A RU 2014115999 A RU2014115999 A RU 2014115999A RU 2014115999 A RU2014115999 A RU 2014115999A
Authority
RU
Russia
Prior art keywords
aquaporin
antibodies
exosomes
urine sample
antibody
Prior art date
Application number
RU2014115999/15A
Other languages
English (en)
Russian (ru)
Inventor
МУНЬОС Карлос Эрнесто ИРАРРАСАБАЛЬ
Original Assignee
Универсидад Де Лос Андес
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47913944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2014115999(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Универсидад Де Лос Андес filed Critical Универсидад Де Лос Андес
Publication of RU2014115999A publication Critical patent/RU2014115999A/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
RU2014115999/15A 2011-09-22 2011-09-22 Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии RU2014115999A (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/054187 WO2013041913A1 (en) 2011-09-22 2011-09-22 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage

Publications (1)

Publication Number Publication Date
RU2014115999A true RU2014115999A (ru) 2015-10-27

Family

ID=47913944

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014115999/15A RU2014115999A (ru) 2011-09-22 2011-09-22 Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии

Country Status (15)

Country Link
US (1) US20140329334A1 (cg-RX-API-DMAC7.html)
EP (1) EP2758774A4 (cg-RX-API-DMAC7.html)
JP (1) JP5893742B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140076571A (cg-RX-API-DMAC7.html)
CN (1) CN103917869A (cg-RX-API-DMAC7.html)
AU (1) AU2011377379A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014006741A2 (cg-RX-API-DMAC7.html)
CA (1) CA2849577A1 (cg-RX-API-DMAC7.html)
HK (1) HK1199754A1 (cg-RX-API-DMAC7.html)
IL (1) IL231626A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN03194A (cg-RX-API-DMAC7.html)
MX (1) MX2014003422A (cg-RX-API-DMAC7.html)
PH (1) PH12014500650A1 (cg-RX-API-DMAC7.html)
RU (1) RU2014115999A (cg-RX-API-DMAC7.html)
WO (1) WO2013041913A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
WO2016011383A1 (en) * 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Methods for using exosomes to monitor transplanted organ status
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
EP3218724A4 (en) * 2014-11-11 2018-08-22 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2016077537A1 (en) * 2014-11-12 2016-05-19 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
WO2016140388A1 (ko) * 2015-03-05 2016-09-09 경북대학교 산학협력단 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법
US20160320390A1 (en) * 2015-05-01 2016-11-03 Morehouse School Of Medicine Compositions and methods for capturing exosomes
EP3334498B1 (en) 2015-08-12 2023-06-07 The Trustees of Columbia University in the City of New York Methods of treating volume depletion and kidney injury
WO2017040520A1 (en) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing urothelial disease
JP6531987B2 (ja) * 2015-10-01 2019-06-19 国立大学法人名古屋大学 腎疾患診断のためのエクソソーム回収法
CN105441578B (zh) * 2016-01-19 2018-08-31 中南大学湘雅二医院 尿液外泌体microRNA分子标志物的应用及制备的试剂盒
WO2017155894A1 (en) 2016-03-07 2017-09-14 Cfgenome, Llc Noninvasive molecular controls
CN106053811A (zh) * 2016-06-05 2016-10-26 浙江大学 一种尿液外泌体elisa的检测方法及其应用
RU2647327C2 (ru) * 2016-07-05 2018-03-15 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО КубГМУ Минздрава России) Способ ранней диагностики хронической болезни почек у пациентов с хронической обструктивной болезнью легких
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法
CN109425742A (zh) * 2017-08-23 2019-03-05 迪亚莱博(张家港)生物科技有限公司 一种化学发光法快速检测水通道蛋白1的试剂盒
JPWO2019045049A1 (ja) * 2017-09-01 2020-12-03 学校法人帝京大学 腎尿細管細胞特異的発現ベクター
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
ES2968898T3 (es) * 2019-06-06 2024-05-14 Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz Método in vitro para detectar enfermedad renal
EP3904883A1 (en) * 2020-04-07 2021-11-03 Sciomics GmbH Prediction and early diagnosis of acute kidney injury
RU2765678C1 (ru) * 2020-12-21 2022-02-01 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования риска развития острого повреждения почек у больных с острым коронарным синдромом
CN113189321B (zh) * 2021-04-12 2024-06-25 攸太科技(台州)有限公司 一种尿液检测方法
WO2024085722A1 (ko) * 2022-10-20 2024-04-25 건국대학교 산학협력단 신장 질환의 조기 진단을 위한 바이오마커 조성물 및 이를 이용한 신장 질환의 조기 진단에 필요한 정보를 제공하는 방법
KR20250003155A (ko) * 2023-06-30 2025-01-07 연세대학교 산학협력단 급성신손상의 회복에 대한 정보 제공 방법 및 이를 이용한 키트
CN116883739A (zh) * 2023-07-10 2023-10-13 中国医学科学院生物医学工程研究所 一种基于图像识别的尿隐血分类方法和系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
WO2004013152A2 (en) * 2002-08-06 2004-02-12 Duke University Novel targets for lithium therapy
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
WO2007127848A1 (en) * 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation of membrane vesicles from biological fluids and methods of using same
KR101970908B1 (ko) * 2008-02-01 2019-04-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
US20110124519A1 (en) * 2008-03-18 2011-05-26 Frank Walter Falkenberg Method of assessing kidney function in a human subject
US7897356B2 (en) * 2008-11-12 2011-03-01 Caris Life Sciences Methods and systems of using exosomes for determining phenotypes
US8394606B2 (en) * 2008-11-05 2013-03-12 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use
CA2744434C (en) * 2008-11-21 2017-10-03 Phadia Ab Methods, devices and kits for detecting or monitoring acute kidney injury
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
WO2010135334A1 (en) * 2009-05-18 2010-11-25 Washington University Methods of renal cancer detection

Also Published As

Publication number Publication date
EP2758774A1 (en) 2014-07-30
US20140329334A1 (en) 2014-11-06
IL231626A0 (en) 2014-05-28
PH12014500650A1 (en) 2014-06-02
AU2011377379A1 (en) 2014-04-10
WO2013041913A1 (en) 2013-03-28
JP5893742B2 (ja) 2016-03-23
CA2849577A1 (en) 2013-03-28
MX2014003422A (es) 2014-10-13
HK1199754A1 (en) 2015-07-17
BR112014006741A2 (pt) 2017-03-28
CN103917869A (zh) 2014-07-09
EP2758774A4 (en) 2015-04-29
KR20140076571A (ko) 2014-06-20
IN2014DN03194A (cg-RX-API-DMAC7.html) 2015-05-22
JP2014528076A (ja) 2014-10-23

Similar Documents

Publication Publication Date Title
RU2014115999A (ru) Способ мониторинга, диагностики и/или прогнозирования острого повреждения почек на ранней стадии
JP2014528076A5 (cg-RX-API-DMAC7.html)
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
AR103935A1 (es) Métodos de detección y cuantificación de il-13 y sus usos en el diagnóstico y tratamiento de enfermedades asociadas a th-2
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
PH12020551371A1 (en) Assays to detect neurodegeneration
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
RU2016137685A (ru) Способ диагностики туберкулеза
Munir et al. Rapid detection of acute kidney injury by urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass surgery
JP7502430B2 (ja) 敗血症管理
RU2013158667A (ru) Способ диагностики болезни гоше
EA201490105A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
JP2018536170A5 (cg-RX-API-DMAC7.html)
JP2012168012A (ja) 血管内皮障害を検査するための新規な検査方法および検査用キット
ES2764225T3 (es) Inmunoensayo para la detección de cromogramina A
JP2021012094A (ja) アルツハイマー病又は発症前アルツハイマー病の診断用マーカー及び診断用キット、脳内へのアミロイドβタンパク質の蓄積量の評価方法、並びに被験者におけるアルツハイマー病又は発症前アルツハイマー病の検出を補助するためのインビトロの方法
JP6893639B2 (ja) がんの判定方法、がんの判定のための装置及びコンピュータプログラム
WO2010006199A3 (en) Immunoassays for the detection of anti -non-muscle myosin heavy chain (nmhc)-ii autoantibodies in cardiovascular diseases
ITRM20100121A1 (it) Marcatori molecolari per infezioni delle vie urinarie.
JP6083937B2 (ja) 急性腎障害の検査方法
Bogo et al. COVID-19: SARS-CoV-2 Seroprevalence in a Blood Bank in Southern Brazil
JP6865280B2 (ja) ヘリコバクター・ピロリ胃炎および萎縮性胃炎と関連リスクの改善された検出方法
Yun et al. Inflammatory dysfunction in hepatitis B-positive individuals: Quantitative assessment of C-reactive protein (CRP) and Procalcitonin (PCT) levels using immunofluorescence assay
US10557857B1 (en) System and method for bone loss assay
Soleimani et al. Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays